Purpose, strategy and culture

Specialty medicines are prescribed by specialist healthcare practitioners. Our portfolio of specialty medicines prevents and treats diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer.

Our portfolio of more than 20 marketed vaccines is one of the broadest in the industry. We deliver more than 1 million doses of our vaccines every day. Our vaccines portfolio targets infectious diseases from birth throughout adulthood.

General medicines are usually prescribed in primary care or community settings by general healthcare practitioners. General medicines include inhalers for asthma and COPD to antibiotics. Every day, our general medicines make life better for millions of people all over the world.

We have a deep understanding of the underlying drivers of disease in different groups of patients with conditions like asthma and COPD. Our ambition is to redefine the future of respiratory medicine with a broad portfolio of next-generation treatments that work in distinct ways to help as many people as possible. We’re building on our decades of knowledge in inflammatory mechanisms to target fibrotic lung, liver and kidney disease.

Our ambition is to help increase overall quality of life, maximize survival and change the course of disease, expanding from our current focus on blood and gynaecological cancers into lung and gastrointestinal cancers, as well as other solid tumours. Our research uses precision medicine-based technology to match the right treatment to the right patient.

Our long-acting HIV medicines have the potential to dramatically change people’s experience by giving them an alternate to daily medicine.

Almost half the vaccines and medicines in our pipeline address infectious diseases, helping protect people from diseases like meningitis, shingles, flu, polio, measles and many more.